[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
Vera
M
M
Pou
M
M
Botey
A
A
Cases
A
A
D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D001002:Anuria / Q000209:etiology*; D000077144:Clopidogrel; D001026:Coronary Artery Bypass; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D020767:Intracranial Thrombosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D018908:Muscle Weakness / Q000139:chemically induced; D009203:Myocardial Infarction / Q000150:complications / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D011183:Postoperative Complications / Q000139:chemically induced; D011725:Pyridines / Q000009:adverse effects* / Q000493:pharmacokinetics; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; D000077144:Clopidogrel; C086276:cerivastatin; D013988:Ticlopidine